In our Stamford practice, we: Review your orthopedic and medical history Evaluate concurrent therapies (PRP, stem cells, surgery, physical therapy) Choose dosing schedules tailored to your goals Monitor progress, side effects, and outcomes We also avoid peptides in certain situations (e.g., active cancer, pregnancy, uncontrolled autoimmune flares) unless carefully coordinated with the rest of your care team
These are illustrative, not a contraindication checklist there is no contraindication table because there is no approved indication: Known or suspected malignancy the proposed pro-angiogenic mechanism (particularly via VEGFR2-Akt-eNOS signaling) raises theoretical concerns about tumor vascularization that have not been characterized in humans Pregnancy or breastfeeding no human reproductive or developmental toxicology data exists Known peptide hypersensitivity or a history of serious peptide-related adverse reactions Athletes subject to anti-doping testing BPC-157 is prohibited by WADA under S0 in-competition and out-of-competition
doi:10.3390/jcm13082176
Sturmlechner, van de B
Conclusion The BPC-157, TB-500, and GHK-Cu peptide blend is utilized in laboratory research to explore peptide-driven signaling across cellular migration, extracellular matrix organization, angiogenic pathways, and oxidative regulation
